Logo image of CSIQ

CANADIAN SOLAR INC (CSIQ) Stock Fundamental Analysis

NASDAQ:CSIQ - Nasdaq - CA1366351098 - Common Stock - Currency: USD

12  +0.28 (+2.39%)

After market: 12.24 +0.24 (+2%)

Fundamental Rating

2

CSIQ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. CSIQ has a bad profitability rating. Also its financial health evaluation is rather negative. CSIQ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CSIQ has reported negative net income.
CSIQ had a negative operating cash flow in the past year.
Each year in the past 5 years CSIQ has been profitable.
In multiple years CSIQ reported negative operating cash flow during the last 5 years.
CSIQ Yearly Net Income VS EBIT VS OCF VS FCFCSIQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of -0.07%, CSIQ is in line with its industry, outperforming 45.45% of the companies in the same industry.
CSIQ has a Return On Equity of -0.37%. This is comparable to the rest of the industry: CSIQ outperforms 43.64% of its industry peers.
Industry RankSector Rank
ROA -0.07%
ROE -0.37%
ROIC N/A
ROA(3y)1.74%
ROA(5y)1.75%
ROE(3y)8.12%
ROE(5y)7.8%
ROIC(3y)N/A
ROIC(5y)N/A
CSIQ Yearly ROA, ROE, ROICCSIQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of CSIQ has declined.
CSIQ has a Gross Margin of 15.14%. This is amonst the worse of the industry: CSIQ underperforms 86.36% of its industry peers.
In the last couple of years the Gross Margin of CSIQ has declined.
CSIQ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-30.67%
PM growth 5Y-35.43%
GM growth 3Y-1.09%
GM growth 5Y-5.77%
CSIQ Yearly Profit, Operating, Gross MarginsCSIQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

0

2. Health

2.1 Basic Checks

CSIQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CSIQ has been increased compared to 1 year ago.
The number of shares outstanding for CSIQ has been increased compared to 5 years ago.
Compared to 1 year ago, CSIQ has a worse debt to assets ratio.
CSIQ Yearly Shares OutstandingCSIQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CSIQ Yearly Total Debt VS Total AssetsCSIQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 0.62, we must say that CSIQ is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CSIQ (0.62) is worse than 71.82% of its industry peers.
CSIQ has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
CSIQ has a worse Debt to Equity ratio (1.37) than 91.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACCN/A
WACC3.89%
CSIQ Yearly LT Debt VS Equity VS FCFCSIQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B 3B

2.3 Liquidity

CSIQ has a Current Ratio of 1.07. This is a normal value and indicates that CSIQ is financially healthy and should not expect problems in meeting its short term obligations.
CSIQ has a Current ratio of 1.07. This is amonst the worse of the industry: CSIQ underperforms 91.82% of its industry peers.
CSIQ has a Quick Ratio of 1.07. This is a bad value and indicates that CSIQ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CSIQ (0.80) is worse than 91.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.8
CSIQ Yearly Current Assets VS Current LiabilitesCSIQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The earnings per share for CSIQ have decreased strongly by -193.75% in the last year.
CSIQ shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.29% yearly.
Looking at the last year, CSIQ shows a very negative growth in Revenue. The Revenue has decreased by -19.06% in the last year.
CSIQ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.37% yearly.
EPS 1Y (TTM)-193.75%
EPS 3Y-26.92%
EPS 5Y-28.29%
EPS Q2Q%-663.16%
Revenue 1Y (TTM)-19.06%
Revenue growth 3Y4.33%
Revenue growth 5Y13.37%
Sales Q2Q%-9.97%

3.2 Future

Based on estimates for the next years, CSIQ will show a very strong growth in Earnings Per Share. The EPS will grow by 52.21% on average per year.
CSIQ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.99% yearly.
EPS Next Y107.79%
EPS Next 2Y72.37%
EPS Next 3Y54.99%
EPS Next 5Y52.21%
Revenue Next Year3.2%
Revenue Next 2Y12.53%
Revenue Next 3Y12.21%
Revenue Next 5Y8.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CSIQ Yearly Revenue VS EstimatesCSIQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
CSIQ Yearly EPS VS EstimatesCSIQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSIQ. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 8.58, which indicates a very decent valuation of CSIQ.
99.09% of the companies in the same industry are more expensive than CSIQ, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.28, CSIQ is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.58
CSIQ Price Earnings VS Forward Price EarningsCSIQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSIQ is valued a bit cheaper than the industry average as 77.27% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.06
CSIQ Per share dataCSIQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

CSIQ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSIQ's earnings are expected to grow with 54.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.37%
EPS Next 3Y54.99%

0

5. Dividend

5.1 Amount

CSIQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CANADIAN SOLAR INC

NASDAQ:CSIQ (8/7/2025, 8:18:55 PM)

After market: 12.24 +0.24 (+2%)

12

+0.28 (+2.39%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)08-21 2025-08-21
Inst Owners48.83%
Inst Owner Change-1.04%
Ins Owners21.18%
Ins Owner ChangeN/A
Market Cap803.64M
Analysts71.76
Price Target13.03 (8.58%)
Short Float %10.9%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-692.5%
Min EPS beat(2)-1389.64%
Max EPS beat(2)4.63%
EPS beat(4)1
Avg EPS beat(4)-367.83%
Min EPS beat(4)-1389.64%
Max EPS beat(4)4.63%
EPS beat(8)3
Avg EPS beat(8)-34.38%
EPS beat(12)7
Avg EPS beat(12)6.9%
EPS beat(16)10
Avg EPS beat(16)32.65%
Revenue beat(2)1
Avg Revenue beat(2)0.97%
Min Revenue beat(2)-5.1%
Max Revenue beat(2)7.03%
Revenue beat(4)2
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-13.65%
Max Revenue beat(4)7.03%
Revenue beat(8)3
Avg Revenue beat(8)-3.47%
Revenue beat(12)5
Avg Revenue beat(12)-3.06%
Revenue beat(16)5
Avg Revenue beat(16)-3.78%
PT rev (1m)-1.71%
PT rev (3m)-17.48%
EPS NQ rev (1m)-11.57%
EPS NQ rev (3m)631.04%
EPS NY rev (1m)0%
EPS NY rev (3m)241.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.12%
Revenue NY rev (1m)1.4%
Revenue NY rev (3m)-12.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.58
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA 13.06
EPS(TTM)-2.7
EYN/A
EPS(NY)1.4
Fwd EY11.65%
FCF(TTM)-39.92
FCFYN/A
OCF(TTM)-12.81
OCFYN/A
SpS87.52
BVpS41.35
TBVpS40.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.14%
FCFM N/A
ROA(3y)1.74%
ROA(5y)1.75%
ROE(3y)8.12%
ROE(5y)7.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-30.67%
PM growth 5Y-35.43%
GM growth 3Y-1.09%
GM growth 5Y-5.77%
F-Score1
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA 10.33
Cap/Depr 362.09%
Cap/Sales 30.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 0.8
Altman-Z 0.62
F-Score1
WACC3.89%
ROIC/WACCN/A
Cap/Depr(3y)379.19%
Cap/Depr(5y)289.93%
Cap/Sales(3y)19.88%
Cap/Sales(5y)15.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-193.75%
EPS 3Y-26.92%
EPS 5Y-28.29%
EPS Q2Q%-663.16%
EPS Next Y107.79%
EPS Next 2Y72.37%
EPS Next 3Y54.99%
EPS Next 5Y52.21%
Revenue 1Y (TTM)-19.06%
Revenue growth 3Y4.33%
Revenue growth 5Y13.37%
Sales Q2Q%-9.97%
Revenue Next Year3.2%
Revenue Next 2Y12.53%
Revenue Next 3Y12.21%
Revenue Next 5Y8.99%
EBIT growth 1Y-137.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year436.59%
EBIT Next 3Y96.51%
EBIT Next 5Y67.37%
FCF growth 1Y-227.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-229.32%
OCF growth 3YN/A
OCF growth 5YN/A